目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Source
1.2.3. Application
1.2.4. End-use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product and source outlook
2.2.2. Application and end use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Monocyte activation test (MAT) Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for safer and more accurate alternatives to LAL (Limulus Amebocyte Lysate) test
3.2.1.2. Rising regulatory requirements for medical devices and pharmaceuticals
3.2.1.3. Growing adoption of in vitro testing methods
3.2.2. Market restraint analysis
3.2.2.1. High initial setup costs
3.2.2.2. Limited standardization and adoption across all regulatory frameworks
3.3. Monocyte activation test (MAT) Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis

Chapter 4. Monocyte activation test (MAT) Market: Product Estimates & Trend Analysis
4.1. Global Monocyte activation test (MAT) Market: Product Dashboard
4.2. Global Monocyte activation test (MAT) Market: Product Movement Analysis
4.3. Global Monocyte activation test (MAT) Market by Product, Revenue
4.4. MAT Kits
4.4.1. MAT kits market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Reagents
4.5.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Monocyte activation test (MAT) Market: Application Estimates & Trend Analysis
5.1. Global Monocyte activation test (MAT) Market: Application Dashboard
5.2. Global Monocyte activation test (MAT) Market: Application Movement Analysis
5.3. Global Monocyte activation test (MAT) Market by Application , Revenue
5.4. Drug Development
5.4.1. Drug Development market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Vaccine Development
5.5.1. Vaccine Development market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Medical Device Testing
5.6.1. Medical Device Testing market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Monocyte activation test (MAT) Market: Source Estimates & Trend Analysis
6.1. Global Monocyte activation test (MAT) Market: Source Dashboard
6.2. Global Monocyte activation test (MAT) Market: Source Movement Analysis
6.3. Global Monocyte activation test (MAT) Market by Source, Revenue
6.4. PBMC Based
6.4.1. PBMC Based market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Cell Line Based
6.5.1. Cell Line Based market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Monocyte activation test (MAT) Market: End use Estimates & Trend Analysis
7.1. Global Monocyte activation test (MAT) Market: End use Dashboard
7.2. Global Monocyte activation test (MAT) Market: End use Movement Analysis
7.3. Global Monocyte activation test (MAT) Market by End use, Revenue
7.4. Pharmaceutical Industry
7.4.1. Pharmaceutical Industry market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Biotechnology Industry
7.5.1. Biotechnology Industry market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Medical Device Industry
7.6.1. Medical Device Industry Analysis market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Monocyte activation test (MAT) Market: Regional Estimates & Trend Analysis by Product, Source, Application and Methodology
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2024
9.3.4. Lonza Group
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Charles River Laboratories
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Bio-Rad Laboratories
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Seikagaku Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Hyglos GmbH
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Hyglos GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Thermo Fisher Scientific
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. MAT BioTech
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Eurofins Scientific
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America Monocyte activation test (MAT) market, by region, 2018 - 2030 (USD Million)
Table 3 North America Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 4 North America Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 5 North America Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 6 North America Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 9 U.S. Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 10 U.S. Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 12 Canada Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 13 Canada Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 14 Canada Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 15 Mexico Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 16 Mexico Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 17 Mexico Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Monocyte activation test (MAT) market, by region, 2018 - 2030 (USD Million)
Table 20 Europe Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 21 Europe Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 22 Europe Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 23 Europe Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 24 Germany Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 25 Germany Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 26 Germany Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 27 Germany Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 28 UK Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 29 UK Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 30 UK Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 31 UK Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 32 France Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 33 France Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 34 France Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 35 France Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 36 Italy Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 37 Italy Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 38 Italy Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 39 Italy Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 40 Spain Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 41 Spain Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 42 Spain Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 43 Spain Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 44 Denmark Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 45 Denmark Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 46 Denmark Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 47 Denmark Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 48 Sweden Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 49 Sweden Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 50 Sweden Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 51 Sweden Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 52 Norway Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 53 Norway Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 54 Norway Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 55 Norway Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Monocyte activation test (MAT) market, by region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 60 Aisa Pacific Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 61 China Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 62 China Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 63 China Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 64 China Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 65 Japan Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 66 Japan Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 67 Japan Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 68 Japan Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 69 India Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 70 India Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 71 India Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 72 India Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 73 South Korea Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 74 South Korea Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 75 South Korea Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 76 South Korea Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 77 Australia Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 78 Australia Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 79 Australia Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 80 Australia Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 81 Thailand Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 82 Thailand Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 83 Thailand Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 84 Thailand Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 85 Latin America Monocyte activation test (MAT) market, by region, 2018 - 2030 (USD Million)
Table 86 Latin America Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 87 Latin America Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 88 Latin America Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 89 Latin America Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 90 Brazil Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 91 Brazil Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 92 Brazil Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 93 Brazil Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 94 Argentina Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 95 Argentina Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 96 Argentina Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 97 Argentina Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 98 MEA Monocyte activation test (MAT) market, by region, 2018 - 2030 (USD Million)
Table 99 MEA Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 100 MEA Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 101 MEA Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 102 MEA Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 103 South Africa Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 104 South Africa Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 105 South Africa Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 106 South Africa Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 111 UAE Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 112 UAE Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 113 UAE Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 114 UAE Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)
Table 115 Kuwait Monocyte activation test (MAT) market, by product, 2018 - 2030 (USD Million)
Table 116 Kuwait Monocyte activation test (MAT) market, by source, 2018 - 2030 (USD Million)
Table 117 Kuwait Monocyte activation test (MAT) market, by application, 2018 - 2030 (USD Million)
Table 118 Kuwait Monocyte activation test (MAT) market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Monocyte activation test (MAT) market: market outlook
Fig. 14 Monocyte activation test (MAT) competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Monocyte activation test (MAT) market driver impact
Fig. 18 Monocyte activation test (MAT) market restraint impact
Fig. 19 Monocyte activation test (MAT) market: Product movement analysis
Fig. 20 Monocyte activation test (MAT) market: Product outlook and key takeaways
Fig. 21 MAT Kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Reagents estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Monocyte activation test (MAT) market: Application movement analysis
Fig. 24 Monocyte activation test (MAT) market: Application outlook and key takeaways
Fig. 25 Drug Development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Vaccine Development estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Medical Device Testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Others estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Monocyte activation test (MAT) market: Source movement analysis
Fig. 30 Monocyte activation test (MAT) market: Source outlook and key takeaways
Fig. 31 PBMC Based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Cell Line Based estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Monocyte activation test (MAT) market: End use movement analysis
Fig. 34 Monocyte activation test (MAT) market: End use outlook and key takeaways
Fig. 35 Pharmaceutical Industry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Biotechnology Industry estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Medical Device Industry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Others estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Global Monocyte activation test (MAT) market: Regional movement analysis
Fig. 40 Global Monocyte activation test (MAT) market: Regional outlook and key takeaways
Fig. 41 Global Monocyte activation test (MAT) market share and leading players
Fig. 42 North America, by country
Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 U.S. key country dynamics
Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Canada key country dynamics
Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Mexico key country dynamics
Fig. 49 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UK key country dynamics
Fig. 52 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Germany key country dynamics
Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 France key country dynamics
Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Italy key country dynamics
Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Spain key country dynamics
Fig. 60 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Norway key country dynamics
Fig. 66 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 China key country dynamics
Fig. 69 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Japan key country dynamics
Fig. 71 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 India key country dynamics
Fig. 73 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Thailand key country dynamics
Fig. 75 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 South Korea key country dynamics
Fig. 77 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Australia key country dynamics
Fig. 79 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Brazil key country dynamics
Fig. 82 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Argentina key country dynamics
Fig. 84 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 South Africa key country dynamics
Fig. 87 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia key country dynamics
Fig. 89 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 UAE key country dynamics
Fig. 91 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Kuwait key country dynamics
Fig. 93 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Market share of key market players- Monocyte activation test (MAT) market